Mizuho lifts McKesson stock target to USD 1,020 from USD 905

Published on 10/27/2026 at 17:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue reached USD 105.38 billion in fiscal 2027 first quarter, up 7.70 percent. McKesson stock costs EUR 880.00 on October 27, 2026.

Analyst target and quarterly results

Mizuho raised its McKesson target to USD 1,020 from USD 905 on October 20, 2026.
Fiscal 2027 first-quarter revenue reached USD 105.38 billion, up 7.70 percent year over year.
McKesson stock costs EUR 880.00 at Lang & Schwarz on October 27, 2026 at 5:01 p.m. CEST.

McKesson, US58155Q1031, Illustration mit AI erstellt.

McKesson Corporation (US58155Q1031) is trading at EUR 880.00 at Lang & Schwarz on October 27, 2026 at 5:01 p.m. CEST. Mizuho raised its McKesson price target to USD 1,020 from USD 905 on October 20, 2026, while keeping a neutral rating, as reported by MarketBeat.

Target sits above the latest quote

The Mizuho target lies 3.99 percent above McKesson's USD 980.89 NYSE quote from October 27, 2026 at 12:04 p.m. EDT. The target change followed a series of upward revisions from firms including UBS and Baird, but Mizuho retained its neutral view.

Revenue rose in the first quarter

McKesson reported USD 105.38 billion of revenue for fiscal 2027 first quarter, 7.70 percent above the prior-year period. The company also reported adjusted earnings per share of USD 9.93, compared with USD 8.26 a year earlier, according to MarketBeat.

Valuation and the next report

McKesson had a market capitalization of USD 114.4 billion and a price-to-earnings ratio of 26.25 as of October 27, 2026. Its 52-week range was USD 723.68 to USD 1,030.27, while the day's volume reached 113,964 shares.

MarketScreener lists November 4, 2026 as the next earnings release date for fiscal 2027 second quarter. That report will provide the next scheduled test of the higher full-year outlook.

Comparison with peers

McKesson: down 1.21 percent, price-to-earnings ratio 26.25, market capitalization USD 114.4 billion. Cardinal Health (NYSE, USD): down 1.37 percent, price-to-earnings ratio 34.32, market capitalization USD 57.4 billion. Cencora (NYSE, USD): down 0.78 percent, price-to-earnings ratio 24.31, market capitalization USD 62.5 billion.

McKesson stock stays near its yearly high

McKesson's latest NYSE quote remains 4.80 percent below its 52-week high of USD 1,030.27. At Lang & Schwarz, the stock was trading at EUR 880.00 on October 27, 2026 at 5:01 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of McKesson stock.